Shopping Cart 0
Cart Subtotal
USD 0

University of Utah - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Utah (University of Utah) is a research university that offers various undergraduate and postgraduate programs. The university offers educational programs in various fields such as architecture and planning, engineering, fine arts, health, humanities, law, medicine, business, dentistry, mines and earth sciences, nursing, pharmacy, science, and others. It also offers support for teaching and research, cooperative education, and teaching hospital services to the university community. University of Utah undertakes research on animal subjects, radiation and laboratory safety, resource for genetic and epidemiologic research, and others. The university offers career services through its career exploration center. The University of Utah is headquartered in Salt Lake City, Utah, the US.

University of Utah-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Utah, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Utah, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Utah, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Utah, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Utah, Medical Devices Deals, 2012 to YTD 2018 10

University of Utah, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Utah, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Venn Therapeutics Enters into Agreement with University of Utah 12

NanoCarrier Enters into Research Agreement with University of Utah 13

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 14

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

Licensing Agreements 17

Crown Bioscience Enters into Licensing Agreement with University of Utah 17

EyeGate Pharma Enters into Licensing Agreement with University Of Utah Research Foundation 18

Navigen Pharma Enters into Licensing Agreement with University of Utah 19

Lone Star Thiotherapies Receives Intellectual Property Rights from University of Utah 20

Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 21

Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 22

University of Utah-Key Competitors 23

University of Utah-Key Employees 24

University of Utah-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 27

Government and Public Interest 27

Sep 07, 2018: Finding that Links ALS/Ataxia to cellular stress opens new approaches for treatment 27

Sep 04, 2018: U research awards pass USD 500 million milestone 28

Jun 06, 2018: Implementing Ccinical whole exome sequencing for the care of children with Mendelian Disorders and cancer 29

Mar 22, 2018: Funding Opportunities Help Scientists Explore the Genetics Behind Disease 30

Mar 15, 2018: Grant Paves Way for U of U Researchers to Use Brain-Imaging Technology to Study Effects of Cannabinoids 32

Mar 13, 2018: Surprising Discovery Provides Insights into Aggressive Endometrial Cancers 33

Mar 06, 2018: Mapping the Genome Jungle: Unique Animal Traits Could Offer Insight into Human Disease 34

Feb 01, 2018: Changes in genes involved in DNA repair and packaging linked to risk of multiple myeloma 36

Jan 29, 2018: Huntsman Cancer Institute Selected as a National Cancer Institute Center for Patient-Derived Model Development 37

Jan 19, 2018: Newly Awarded III Seed Grant Projects Explore the Role of Immune System in Disease 38

Nov 06, 2017: Huntsman Cancer Institute Study Identifies Enhanced Impact of Treatment for Hereditary Cancer Patients 39

Nov 01, 2017: University of Utah Receives USD 47.5 Million Gift from Craig H. Neilsen Foundation for New State-of-the-Art Rehabilitation Hospital 40

Oct 25, 2017: Huntsman Cancer Institute's Researchers Develop New Method for Gene Silencing 41

Oct 17, 2017: USD 24 Million NIH Grant Funds HIV Research at U of U Health-Led CHEETAH Center 42

Oct 10, 2017: National MS Society Commits Nearly USD 14 Million to New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever 43

Oct 06, 2017: FDA awards six grants for natural history studies in rare diseases 44

Oct 05, 2017: New Research on Sperm Stem Cells has Implications for Male Infertility and Cancer 45

Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 46

Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 48

Product News 49

Jan 30, 2018: University of Utah researchers find novel way to treat opioid addiction 49

Other Significant Developments 50

Aug 08, 2018: Proof-of-concept technique makes nanoparticles attractive for new medications 50

Dec 21, 2017: New Cancer Treatment Technology Coming to Utah 51

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

University of Utah, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Utah, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Utah, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Utah, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Utah, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Utah, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Utah, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Utah, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Utah, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Utah, Pharmaceuticals & Healthcare, Key Facts 2

University of Utah, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Utah, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Utah, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Utah, Deals By Therapy Area, 2012 to YTD 2018 9

University of Utah, Medical Devices Deals, 2012 to YTD 2018 10

University of Utah, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Venn Therapeutics Enters into Agreement with University of Utah 12

NanoCarrier Enters into Research Agreement with University of Utah 13

Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 14

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

Crown Bioscience Enters into Licensing Agreement with University of Utah 17

EyeGate Pharma Enters into Licensing Agreement with University Of Utah Research Foundation 18

Navigen Pharma Enters into Licensing Agreement with University of Utah 19

Lone Star Thiotherapies Receives Intellectual Property Rights from University of Utah 20

Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 21

Kineta Enters Into Licensing Agreement With University of Utah Research Foundation 22

University of Utah, Key Competitors 23

University of Utah, Key Employees 24

University of Utah, Other Locations 25

University of Utah, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Utah, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.